Literature DB >> 1944606

Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ.

Q Timour1, J F Aupetit, J Loufoua-Moundanga, I Gerentes-Chassagne, I Kioueh, G Faucon.   

Abstract

The effects of three Ic antiarrhythmic drugs, flecainide, propafenone and cibenzoline, were investigated in anaesthetized, open-chest pigs, in a left ventricular area, during pacing at a constant high rate (180 beats min-1), in the absence and the presence of ischaemia. Ischaemia was produced by transient complete occlusion of the left anterior descending coronary artery 1-1.5 cm from its origin. In addition to surface electrocardiogram, conduction time and monophasic action potential were recorded in the contractile fibres. Measurement of the effective refractory period was added in the absence of ischaemia. In this event, flecainide and propafenone, each in a dose of 2.5 mg kg-1 i.v. and cibenzoline, 2.0 mg kg-1, i.v., considerably lengthened (by 50-90%) conduction time, but did not affect or hardly affected the duration of the monophasic action potential or the effective refractory period. Thus, it seems that these Ic antiarrhythmic drugs enhance the prolongation of conduction time by 60% and do not prevent the 30% shortening of monophasic action potential caused by ischaemia: contrary to expectation, they produced a large reduction (from about 120 to 25 s) in the onset time of fibrillation due to ischaemia. Thus, they manifested profibrillatory properties (more pronounced than those of other class I antiarrhythmic drugs), which might be explained by their potent action on depolarization with almost total absence of action on repolarization.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1944606     DOI: 10.1007/bf00184297

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  34 in total

1.  The effect of the cardiac membrane potential on the rapid availability of the sodium-carrying system.

Authors:  S WEIDMANN
Journal:  J Physiol       Date:  1955-01-28       Impact factor: 5.182

Review 2.  Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction.

Authors:  M J Janse; A L Wit
Journal:  Physiol Rev       Date:  1989-10       Impact factor: 37.312

3.  Potentiation by mild hypothermia of ventricular conduction disturbances and reentrant arrhythmias induced by bupivacaine in dogs.

Authors:  M Freysz; Q Timour; R I Mazze; L Bertrix; S Cohen; K Samii; G Faucon
Journal:  Anesthesiology       Date:  1989-05       Impact factor: 7.892

4.  Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide.

Authors:  T J Campbell; E M Vaughan Williams
Journal:  Cardiovasc Res       Date:  1983-05       Impact factor: 10.787

5.  Clinical electrophysiologic study of antiarrhythmic properties of flecainide: acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed stimulation.

Authors:  S B Olsson; N Edvardsson
Journal:  Am Heart J       Date:  1981-11       Impact factor: 4.749

6.  Anti-ischemic effects of trimetazidine: 31P-NMR spectroscopy in the isolated rat heart.

Authors:  N Lavanchy; J Martin; A Rossi
Journal:  Arch Int Pharmacodyn Ther       Date:  1987-03

7.  Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.

Authors:  V Velebit; P Podrid; B Lown; B H Cohen; T B Graboys
Journal:  Circulation       Date:  1982-05       Impact factor: 29.690

8.  Antiarrhythmic effects of flecainide.

Authors:  P Somani
Journal:  Clin Pharmacol Ther       Date:  1980-04       Impact factor: 6.875

9.  Internal pH, Na+, and Ca2+ regulation by trimetazidine during cardiac cell acidosis.

Authors:  J F Renaud
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

10.  Cardiac effects of cibenzoline.

Authors:  K H Dangman
Journal:  J Cardiovasc Pharmacol       Date:  1984 Mar-Apr       Impact factor: 3.105

View more
  6 in total

1.  Time course of electrical fibrillation threshold during brief periods of myocardial ischemia and the genesis of fibrillation: role of calcium.

Authors:  Q Timour; J F Aupetit; G Chevrel; J Loufoua-Moundanga; S Omar; G Faucon
Journal:  Cardiovasc Drugs Ther       Date:  1994-12       Impact factor: 3.727

2.  The effects of ropivacaine at clinically relevant doses on myocardial ischemia in pigs.

Authors:  Panayota Tsibiribi; Cécile Bui-Xuan; Bernard Bui-Xuan; Alain Tabib; Jacques Descotes; Philippe Chevalier; Marie-Claude Gagnieu; Majda Belkhiria; Quadiri Timour
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

3.  Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.

Authors:  J Leboeuf; M Basiez; R Massingham
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

Review 4.  Cibenzoline. A review of its pharmacological properties and therapeutic potential in arrhythmias.

Authors:  D W Harron; R N Brogden; D Faulds; A Fitton
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

5.  Trimetazidine demonstrated cardioprotective effects through mitochondrial pathway in a model of acute coronary ischemia.

Authors:  L Dehina; F Vaillant; A Tabib; B Bui-Xuan; Ph Chevalier; N Dizerens; C Bui-Xuan; J Descotes; V Blanc-Guillemaud; L Lerond; Q Timour
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-22       Impact factor: 3.000

6.  Attenuation of the ischaemia-induced fall of electrical ventricular fibrillation threshold by a calcium antagonist, diltiazem.

Authors:  J F Aupetit; Q Timour; G Chevrel; J Loufoua-Moundanga; S Omar; G Faucon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.